AZD-2327
A drug candidate for the treatment of anxiety and depression
AZD-2327 is a chemical compound that was developed as a potential therapeutic agent for the treatment of anxiety and depression. It is classified as a serotonin receptor agonist, specifically targeting the 5-HT1A receptor.
Pharmacology
AZD-2327 acts primarily as a selective agonist at the 5-HT1A receptor, a subtype of the serotonin receptor. The 5-HT1A receptor is involved in the modulation of mood and anxiety, making it a target for the development of anxiolytic and antidepressant drugs. By activating this receptor, AZD-2327 is believed to enhance serotonergic neurotransmission, which can lead to improved mood and reduced anxiety symptoms.
Development and Research
AZD-2327 was developed by AstraZeneca, a pharmaceutical company known for its research in central nervous system disorders. The compound was investigated in preclinical and early clinical trials to assess its efficacy and safety profile. Initial studies suggested that AZD-2327 had potential benefits in reducing symptoms of anxiety and depression, but further research was needed to confirm these findings.
Mechanism of Action
The mechanism of action of AZD-2327 involves its interaction with the 5-HT1A receptor. As a partial agonist, AZD-2327 binds to this receptor and mimics the action of serotonin, a neurotransmitter that plays a key role in mood regulation. This interaction is thought to result in increased serotonergic activity in the brain, which can alleviate symptoms of anxiety and depression.
Clinical Trials
Clinical trials for AZD-2327 were conducted to evaluate its therapeutic potential in humans. These trials aimed to determine the optimal dosing, efficacy, and safety of the compound. However, the development of AZD-2327 was eventually discontinued, and it did not reach the market as a therapeutic agent.
Potential Applications
Although AZD-2327 did not advance to commercialization, its development contributed to the understanding of 5-HT1A receptor agonists in the treatment of mood disorders. Research on similar compounds continues, with the goal of finding effective treatments for anxiety and depression.
Related pages
Ad. Transform your life with W8MD's Budget GLP-1 injections from $29.99
W8MD offers medical weight loss programs including NYC medical weight loss and Philadelphia medical weight loss offering:
- Affordable GLP1 shots (generic and brand names) such as
- Wegovy NYC (Semaglutide)
- Zepbound NYC /
- Learn more: Budget GLP1 weight loss injections NYC & Philadelphia GLP1 weight loss shots
- Most insurances accepted
- Lowest cost GLP1 weight loss NYC such as Semaglutide starting from $29.99/week and $45.00/week (Tirzepatide) with insurance.
- Prescription weight loss NYC including:
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your physician weight loss journey today at our:
- NYC medical weight loss
- Philadelphia medical weight loss
- Call 718-946-5500 for NYC or 215-676-2334 for Philadelphia
- Tags:
Budget glp1 weight loss NYC,
Zepbound NYC,
Philadelphia medical weight loss,
Wegovy NYC,
Budget Zepbound Philadelphia,
[** https://w8md.org/?page_id=62216 Affordable glp1 shots Philadelphia]
YouTube_icon_(2011-2013)
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
.svg){kind=link}